🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Innovative Patient-partner-guided Virtual Group Speech Pathology Intervention Model in Head and Neck Cancer

RecruitingPhase 1, Phase 2Ages 18 Years - anyAllCentre hospitalier de l'Université de Montréal (C…
NCT05621889 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This project aims to study an innovative intervention, the eG2 Intervention, developed by speech-language pathologists at the Centre hospitalier de l'Université de Montréal to improve therapeutic adherence and prevent dysphagia in patients treated with chemoradiotherapy for head and neck cancer. The innovation consists in offering a speech therapy intervention that is 1) virtual, 2) group-based (whereas it is usually individual) and 3) involves a patient partner. This intervention has the potential to improve quality of care, accessibility to services and optimize health care resources.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults ≥ 18 years of age with a diagnosis of head or neck cancer * Chemoradiotherapy treatments planned for curative purposes * Planned external radiation therapy dose of at least ≥60 Grays * Sufficient proficiency in French to complete self-reported questionnaires Exclusion Criteria: * Remote metastases * Previous or planned total laryngectomy * Previous moderate/severe dysphagia known and/or evaluated by speech therapy * Diagnosis of a second synchronous cancer at the time of study enrollment * History of prior radiation therapy to the head and neck area * Have a cognitive impairment (diagnosed or suspected) that may significantly interfere with participation in the intervention and various measurement procedures.
💊

What it tests

  • virtual group speech therapy intervention guided by a patient partner
📍

Where

1 site
Centre Hospitalier de l'Université de Montréal
Montreal, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy